相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells
Andrew S. Dixon et al.
ACS CHEMICAL BIOLOGY (2016)
Detection and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay
Annelies Cannaert et al.
ANALYTICAL CHEMISTRY (2016)
Amide bond-containing monodisperse polyethylene glycols beyond 10 000 Da
Zihong Wan et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2016)
Structure-guided development of heterodimer-selective GPCR ligands
Harald Huebner et al.
NATURE COMMUNICATIONS (2016)
KLHL12 Promotes Non-Lysine Ubiquitination of the Dopamine Receptors D4.2 and D4.4, but Not of the ADHD-Associated D4.7 Variant
Kamila Skieterska et al.
PLOS ONE (2015)
Kinetic analysis of antagonist-occupied adenosine-A3 receptors within membrane microdomains of individual cells provides evidence of receptor dimerization and allosterism
Ross Corriden et al.
FASEB JOURNAL (2014)
Bivalent Ligands That Target μ Opioid (MOP) and Cannabinoid1 (CB1) Receptors Are Potent Analgesics Devoid of Tolerance
Morgan Le Naour et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
An easy access to asymmetrically substituted oligoethylene glycols from 18-crown-6
Polina I. Abronina et al.
TETRAHEDRON LETTERS (2013)
Novel Bivalent Ligands for D2/D3 Dopamine Receptors: Significant Cooperative Gain in D2 Affinity and Potency
Sanjib Gogoi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Effect of acute and continuous morphine treatment on transcription factor expression in subregions of the rat caudate putamen. Marked modulation by D4 receptor activation
Belen Gago et al.
BRAIN RESEARCH (2011)
Agonist-directed Interactions with Specific β-Arrestins Determine μ-Opioid Receptor Trafficking, Ubiquitination, and Dephosphorylation
Chad E. Groer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Bivalent Dopamine D2 Receptor Ligands: Synthesis and Binding Properties
Julia Kuehhorn et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
N-naphthoyl-β-naltrexamine (NNTA), a highly selective and potent activator of μ/κ-opioid heteromers
Ajay S. Yekkirala et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
In Vitro and In Vivo Comparison of [3H](+)-PHNO and [3H]Raclopride Binding to Rat Striatum and Lobes 9 and 10 of the Cerebellum: A Method to Distinguish Dopamine D3 From D2 Receptor Sites
Bela Kiss et al.
SYNAPSE (2011)
The role of dimerisation in the cellular trafficking of G-protein-coupled receptors
Graeme Milligan
CURRENT OPINION IN PHARMACOLOGY (2010)
Synthesis and ligation ability of mono-aminooxy-functionalized dendrigraft poly-L-lysine (DGL)
Andrea Molero Bondia et al.
TETRAHEDRON LETTERS (2010)
Mixed κ/μ Opioid Receptor Agonists: The 6β-Naltrexamines
Gerta Cami-Kobeci et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Adenosine A2A Receptor-Antagonist/Dopamine D2 Receptor-Agonist Bivalent Ligands as Pharmacological Tools to Detect A2A-D2 Receptor Heteromers
Aroa Soriano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophrenia
Kjell Fuxe et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
BTB protein KLHL12 targets the dopamine D4 receptor for ubiquitination by a Cul3-based E3 ligase
Pieter Rondou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Synthesis and biological evaluation of α- and β-6-amido derivatives of 17-cyclopropylmethyl-3, 14β-dihydroxy-4, 5α-epoxymorphinan:: Potential alcohol-cessation agents
Senait Ghirmai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opiold receptor antagonist pharmacophores
Natalie R. Lenard et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Dopamine D4 receptor activation decreases the expression of μ-opioid receptors in the rat striatum
Belen Gago et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2007)
Different effects of opioid antagonists on μ-, δ-, and κ-opioid receptors with and without agonist pretreatment
Danxin Wang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
An opioid agonist that does not induce μ-opioid receptor -: Arrestin interactions or receptor internalization
C. E. Groer et al.
MOLECULAR PHARMACOLOGY (2007)
Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series
DJ Daniels et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Methods to monitor the quaternary structure of G protein-coupled receptors
G Milligan et al.
FEBS JOURNAL (2005)
Folding efficiency is rate-limiting in dopamine D4 receptor biogenesis
K Van Craenenbroeck et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A bivalent ligand (KDAN-18) containing δ-antagonist and k-agonist pharmacophores bridges δ2 and k1 opioid receptor phenotypes
DJ Daniels et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Ultrastructural evidence for co-localization of dopamine D2 and μ-opioid receptors in the rat dorsolateral striatum
LM Ambrose et al.
ANATOMICAL RECORD PART A-DISCOVERIES IN MOLECULAR CELLULAR AND EVOLUTIONARY BIOLOGY (2004)
μ-Receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man
N Hagelberg et al.
SYNAPSE (2002)
Dopamine D-4 receptors are heterogeneously distributed in the striosomes/matrix compartments of the striatum
A Rivera et al.
JOURNAL OF NEUROCHEMISTRY (2002)
From models to molecules: Opioid receptor dimers, bivalent ligands, and selective opioid receptor probes
PS Portoghese
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Region specific increase of dopamine receptor D1/D2 mRNA expression in the brain of μ-opioid receptor knockout mice
Y Park et al.
BRAIN RESEARCH (2001)
A novel pharmacological approach to treating cardiac ischemia -: Binary conjugates of A1 and A3 adenosine receptor agonists
KA Jacobson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
